The European Commission approved of 3-fucosyllactose as a novel food ingredient, marking a milestone for improving market access of a broader range of HMOs.
The prebiotic fiber received approval for eight claims in total, and unrestricted use in dietary supplements regulated by the Therapeutic Goods Administration.
The mushroom supplement manufacturer founded by mycologist Paul Stamets achieved the certification for its ESG performance, accountability, and transparency.